OncoMed Pharmaceuticals is a clinical-stage biotechnology company dedicated to improving cancer treatment by creating novel medicines that address the fundamental biologic pathways critical to tumor initiation, growth, metastases and recurrence. We are leveraging our understanding of cancer stem cell pathways and immuno-oncology targets to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer.
For Cancer Patients
Clinical trials are essential to obtain the data required for regulatory approval in order to make new medicines broadly available to patients and their prescribing physicians. OncoMed is currently conducting numerous clinical trials of our therapeutic candidates. To participate in one of our ongoing clinical trials, contact the OncoMed Clinical Trial Matching Service at 866-914-7347 (USA) or email@example.com.